Javascript must be enabled to continue!
Double strand RNA‐guided endogeneous E‐cadherin up‐regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo
View through CrossRef
E‐cadherin plays a crucial role in epithelial cell–cell adhesion and in the maintenance of tissue architecture. Down‐regulation of E‐cadherin expression correlates with a strong invasive potential, resulting in poor prognosis in many human carcinomas, including breast cancer. Restoration of E‐cadherin can inhibit cell invasion and metastasis in many types of tumors. It has been demonstrated that promoter hypermethylation causes transcriptional down‐regulation of E‐cadherin. Here, using an RNAa technique specifically activating the expression of E‐cadherin through transcriptional regulation, we assessed the phenotype changes of a breast carcinoma cell line with transfection of small‐activating RNAs (saRNAs). We observed cell apoptosis, proliferation inhibition and reduction in human breast cancer migration in vitro. Animal experiment results showed that saRNA could inhibit tumor growth in vivo compared with scramble double‐small RNA (dsRNA).This study provides a new potential strategy for breast cancer therapy, and also demonstrates the potential for saRNA as a therapeutic option for enhancing tumor suppressor gene expression in breast cancer. (Cancer Sci 2010)
Title: Double strand RNA‐guided endogeneous E‐cadherin up‐regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo
Description:
E‐cadherin plays a crucial role in epithelial cell–cell adhesion and in the maintenance of tissue architecture.
Down‐regulation of E‐cadherin expression correlates with a strong invasive potential, resulting in poor prognosis in many human carcinomas, including breast cancer.
Restoration of E‐cadherin can inhibit cell invasion and metastasis in many types of tumors.
It has been demonstrated that promoter hypermethylation causes transcriptional down‐regulation of E‐cadherin.
Here, using an RNAa technique specifically activating the expression of E‐cadherin through transcriptional regulation, we assessed the phenotype changes of a breast carcinoma cell line with transfection of small‐activating RNAs (saRNAs).
We observed cell apoptosis, proliferation inhibition and reduction in human breast cancer migration in vitro.
Animal experiment results showed that saRNA could inhibit tumor growth in vivo compared with scramble double‐small RNA (dsRNA).
This study provides a new potential strategy for breast cancer therapy, and also demonstrates the potential for saRNA as a therapeutic option for enhancing tumor suppressor gene expression in breast cancer.
(Cancer Sci 2010).
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract
BACKGROUND
Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer agent...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract
IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract
Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...
Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells through Wnt Signaling Pathway
Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells through Wnt Signaling Pathway
Abstract
Objective: To compare and analyze the effect of N-cadherin on chondrogenic differentiation of bone marrow derived mesenchymal stem cells (BMSCs) and to explore the...
Data from P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma
Data from P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma
<div>Abstract<p>Malignant transformation of melanocytes frequently coincides with alterations in epithelial cadherin (E-cadherin) expression, switching on of neural cad...
Data from P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma
Data from P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma
<div>Abstract<p>Malignant transformation of melanocytes frequently coincides with alterations in epithelial cadherin (E-cadherin) expression, switching on of neural cad...

